Product Images Cinacalcet

This is a graph showing the serum calcium levels in patients with parathyroid carcinoma receiving Cinacalcet at different stages; baseline, titration, and maintenance. The graph displays the serum calcium levels (in mg/dL) for each week ranging from week 8 to week 80. The number of patients in the study is also shown.*

This is a graph of mean (SE) iPTH values (in pg/mL) in pooled phase 3 studies. The x-axis shows the weeks of the study and the y-axis shows the iPTH values ranging from 0-1000 pg/mL. The graph compares the iPTH values of patients who were administered cinacalcet versus placebo. The data suggests that cinacalcet was effective in reducing iPTH levels compared to the placebo.*

Cinacalcet Tablets are identified by the National Drug Code (NDC) 47335-379-83. No further information available.*

This is a label for Cinacalcet Tablets, a prescription medication with NDC number 47335-380-83. The label indicates that there are 30 tablets in each bottle and that it is only available with a prescription. However, due to the limited information and lack of readable text, it is not possible to provide a full and accurate description of the product.*

This is a medication called Cinacalcet Tablets, which are film-coated tablets that contain 99mg of cinacalcet hydrochloride, equivalent to 90mg of cinacalcet. The usual dosage information is not provided and can be found on the prescribing information. It should be stored between 20° to 25°C (68° to 77°F), and can tolerate excursions between 15° to 30°C (59° to 86°F) as defined in the USP Controlled Room Temperature. This medication is sold by Sun Pharmaceutical Industries and should be dispensed in a tightly closed, light-resistant container. The manufacturer is Sun Pharmaceutical Industries Limited located in India. No further information is provided.*